Corpovael Valuation Multiples

Discover revenue and EBITDA valuation multiples for Corpovael and similar public comparables like Polski Holding Nieruchomoƛci, FCR Immobilien, KD, Daidoh and more.

Corpovael Overview

About Corpovael

Corpovael SA de CV is engaged in developing, building and commercializing accessible housing for the middle and lower level of the Mexicans. The company seeks new investment alternatives in other States of the Republic in order to provide a home for more Mexicans.


Founded

2007

HQ

Mexico

Employees

N/A

Financials (LTM)

Revenue: $295M
EBITDA: $46M

EV

$199M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Corpovael Financials

Corpovael reported last 12-month revenue of $295M and EBITDA of $46M.

In the same LTM period, Corpovael generated $70M in gross profit, $46M in EBITDA, and $24M in net income.

Revenue (LTM)


Corpovael P&L

In the most recent fiscal year, Corpovael reported revenue of $295M and EBITDA of $46M.

Corpovael is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 15%, and net margin of 8%.

See analyst estimates for Corpovael
LTMLast FY202320242025202620272028
Revenue$295M$295M$258M$257M$290M
Gross Profit$70M$69M$70M$69M$69M
Gross Margin24%23%27%27%24%
EBITDA$46M$46M$32M$27M$32M
EBITDA Margin15%15%13%11%11%
EBIT Margin9%9%12%10%9%
Net Profit$24M$24M$17M$13M$24M
Net Margin8%8%7%5%8%
Net Debt-$73M---

Financial data powered by Morningstar, Inc.

Corpovael Stock Performance

Corpovael has current market cap of $125M, and enterprise value of $199M.

Market Cap Evolution


Corpovael's stock price is $0.43.

Corpovael share price increased by 0.1% in the last 30 days, and by 124.5% in the last year.

Corpovael has an EPS (earnings per share) of $0.08.

See more trading valuation data for Corpovael
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$199M$125M-0.0%0.1%-2.7%124.5%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Corpovael Valuation Multiples

Corpovael trades at 0.7x EV/Revenue multiple, and 4.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Corpovael

EV / Revenue (LTM)


Corpovael Financial Valuation Multiples

As of July 6, 2026, Corpovael has market cap of $125M and EV of $199M.

Corpovael has a P/E ratio of 5.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.8x0.8x0.7x
EV/EBITDA4.4x4.4x6.1x7.3x6.2x
EV/EBIT7.3x7.3x6.6x8.0x7.4x
EV/Gross Profit2.9x2.9x2.8x2.9x2.9x
P/E5.2x5.2x7.4x9.4x5.3x
EV/FCF-4.0x2.6x18.7x4.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Corpovael Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Corpovael Margins & Growth Rates

In the most recent fiscal year, Corpovael reported gross margin of 23%, EBITDA margin of 15%, and net margin of 8%.

See estimated margins and future growth rates for Corpovael

Corpovael Margins

Last FY20242025202720282029
Gross Margin23%27%24%
EBITDA Margin15%11%11%
EBIT Margin9%10%9%
Net Margin8%5%8%
FCF Margin17%4%17%

Corpovael Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(0%)13%
Gross Profit Growth(2%)0%
EBITDA Growth(16%)19%
EBIT Growth(17%)8%
Net Profit Growth(22%)78%
FCF Growth(86%)362%

Data powered by FactSet, Inc. and Morningstar, Inc.

Corpovael Operational KPIs

Access forward-looking KPIs for Corpovael
Last FY202320242025202620272028
S&M Expenses to Revenue8%9%10%8%
G&A Expenses to Revenue0%0%0%0%
Opex to Revenue14%15%17%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Corpovael Competitors

Corpovael competitors include Polski Holding Nieruchomoƛci, FCR Immobilien, KD, Daidoh, ACRES Commercial Realty, Fortinova Fastigheter, Balwin Properties, AGROB Immobilien, Deutsche Fachmarkt and Crosswood.

Most Corpovael public comparables operate across Real Estate Development.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Polski Holding Nieruchomoƛci2.6x-5.9x-
FCR Immobilien10.2x10.5x18.4x17.8x
KD5.0x-5.7x-
Daidoh0.9x0.8x(13.7x)-
ACRES Commercial Realty22.3x25.3x--
Fortinova Fastigheter10.0x-14.5x-
Balwin Properties1.8x-11.4x-
AGROB Immobilien18.0x-26.3x-

This data is available for Pro users. Sign up to see all Corpovael competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Corpovael

When was Corpovael founded?Corpovael was founded in 2007.
Where is Corpovael headquartered?Corpovael is headquartered in Mexico.
Is Corpovael publicly listed?Yes, Corpovael is a public company listed on Bolsa Mexicana de Valores.
What is the stock symbol of Corpovael?Corpovael trades under CADUA ticker.
When did Corpovael go public?Corpovael went public in 2015.
Who are competitors of Corpovael?Corpovael main competitors include Polski Holding Nieruchomoƛci, FCR Immobilien, KD, Daidoh, ACRES Commercial Realty, Fortinova Fastigheter, Balwin Properties, AGROB Immobilien, Deutsche Fachmarkt, Crosswood.
What is the current market cap of Corpovael?Corpovael's current market cap is $125M.
What is the current revenue of Corpovael?Corpovael's last 12 months revenue is $295M.
What is the current EV/Revenue multiple of Corpovael?Current revenue multiple of Corpovael is 0.7x.
What is the current EBITDA of Corpovael?Corpovael's last 12 months EBITDA is $46M.
What is Corpovael's EBITDA margin?Corpovael's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Corpovael?Current EBITDA multiple of Corpovael is 4.4x.
How many companies Corpovael has acquired to date?Corpovael hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Corpovael has invested to date?Corpovael hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Corpovael

Lists including Corpovael

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial